Intracranial gadolinium deposition after contrast-enhanced MR imaging
Abstract
PURPOSE: To determine if repeated intravenous exposures to gadolinium-based contrast agents (GBCAs) are associated with neuronal tissue deposition. MATERIALS AND METHODS: In this institutional review board-approved single-center study, signal intensities from T1-weighted magnetic resonance (MR) images and postmortem neuronal tissue samples from 13 patients who underwent at least four GBCA-enhanced brain MR examinations between 2000 and 2014 (contrast group) were compared with those from 10 patients who did not receive GBCA (control group). Antemortem consent was obtained from all study participants. Neuronal tissues from the dentate nuclei, pons, globus pallidus, and thalamus of these 23 deceased patients were harvested and analyzed with inductively coupled plasma mass spectrometry (ICP-MS), transmission electron microscopy, and light microscopy to quantify, localize, and assess the effects of gadolinium deposition. Associations between cumulative gadolinium dose, changes in T1-weighted MR signal intensity, and ICP-MS-derived tissue gadolinium concentrations were examined by using the Spearman rank correlation coefficient (ρ). RESULTS: Compared with neuronal tissues of control patients, all of which demonstrated undetectable levels of gadolinium, neuronal tissues of patients from the contrast group contained 0.1-58.8 μg gadolinium per gram of tissue, in a significant dose-dependent relationship that correlated with signal intensity changes on precontrast T1-weighted MR images (ρ = 0.49-0.93). All patients in the contrast group had relatively normal renal function at the time of MR examination. Gadolinium deposition in the capillary endothelium and neural interstitium was observed only in the contrast group. CONCLUSION: Intravenous GBCA exposure is associated with neuronal tissue deposition in the setting of relatively normal renal function. Additional studies are needed to investigate the clinical significance of these findings and the generalizability to other GBCAs. Online supplemental material is available for this article.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ferumoxytol does not extravasate into surrounding tissue and allows more reliable rCBV measurements, depicting GBM treatment success more precisely than gadolinium agents.
“In contrast, ferumoxytol does not extravasate into the surrounding tissue and hence allows more reliable rCBV measurements depicting treatment success of GBM more precisely [191] (Figure 5A).”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [191]
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079 · see citing works
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P. D., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,491 · see citing works
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,862 · see citing works
Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., & Takenaka, D. (2013) · Radiology · doi:10.1148/radiol.13131669 · Cited by 1,341 · see citing works
Edelman, R. R., & Warach, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303183281109 · Cited by 1,207 · see citing works
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J. P., Zito, G., & Cowper, S. E. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 542 · see citing works
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
Aime, S., & Caravan, P. D. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21969 · Cited by 535 · see citing works
The relationship between thermodynamics and the toxicity of gadolinium complexes
Cacheris, W. P., Quay, S. C., & Rocklage, S. M. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90055-7 · Cited by 438 · see citing works
Gadolinium‐based contrast agents for magnetic resonance cancer imaging
Zhou, Z., & Lu, Z. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1198 · Cited by 431 · see citing works
Errante, Y., Cirimele, V., Mallio, C. A., Lazzaro, V. D., Zobel, B. B., & Quattrocchi, C. C. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000072 · Cited by 421 · see citing works
White, G. W., Gibby, W. A., & Tweedle, M. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186569.32408.95 · Cited by 363 · see citing works
MRI contrast agents: Basic chemistry and safety
Hao, D., Ai, T., Goerner, F. L., Hu, X., Runge, V. M., & Tweedle, M. F. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23725 · Cited by 338 · see citing works
Incorporation of excess gadolinium into human bone from medical contrast agents
Darrah, T. H., Prutsman-Pfeiffer, J. J., Poreda, R. J., et al. (2009) · Metallomics · doi:10.1039/b905145g · Cited by 304 · see citing works
Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex
Brasch, R. C., Weinmann, H., & Wesbey, G. E. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.625 · Cited by 303 · see citing works
Edelman, R. R., & Warach, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281008 · Cited by 213 · see citing works
Harpur, E. S., Worah, D. M., Hals, P., Holtz, E., Furuhama, K., & NOMURA, H. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00004 · Cited by 157 · see citing works
Biodistribution and toxicity of MR imaging contrast media
Øksendal, A. N., & Hals, P. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030128 · Cited by 156 · see citing works
Telgmann, L., Sperling, M., & Kärst, U. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.12.007 · Cited by 140 · see citing works
Roccatagliata, L., Vuolo, L., Bonzano, L., Pichiecchio, A., & Mancardi, G. (2009) · Radiology · doi:10.1148/radiol.2511081269 · Cited by 114 · see citing works
Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man
Moreau, J., Droz, D., Sabto, J., et al. (1975) · Radiology · doi:10.1148/115.2.329 · Cited by 111 · see citing works
WAGONER, M. V., O'toole, M., Worah, D., et al. (1991) · Investigative Radiology · doi:10.1097/00004424-199111000-00010 · Cited by 79 · see citing works
Amet, S., Launay‐Vacher, V., Clémеnt, O., et al. (2013) · Investigative Radiology · doi:10.1097/rli.0000000000000000 · Cited by 72 · see citing works
WAGONER, M. V., & Worah, D. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00005 · Cited by 54 · see citing works
Pietsch, H., Raschke, M., Ellinger-Ziegelbauer, H. C., et al. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181efd49a · Cited by 43 · see citing works
Imaging of Bilateral Striopallidodentate Calcinosis
Ogi, S., Fukumitsu, N., Tsuchida, D., et al. (2002) · Clinical Nuclear Medicine · doi:10.1097/00003072-200210000-00008 · Cited by 34 · see citing works
Kaplan, G. D., Aisen, A. M., & Aravapalli, S. (1991) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880010107 · Cited by 21 · see citing works
Functional requirements of a desktop clinical image display application
Erickson, B. J., Ryan, W. J., & Gehring, D. G. (2001) · Journal of Imaging Informatics in Medicine · doi:10.1007/bf03190322 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works
Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI
Gong, E., Pauly, J. M., Wintermark, M., & Zaharchuk, G. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25970 · Cited by 351 · see citing works
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
Do, C., DeAguero, J., Brearley, A., Trejo, X., Howard, T., Escobar, G. P., & Wagner, B. (2020) · Kidney360 · doi:10.34067/kid.0000272019 · Cited by 125 · see citing works
Hsu, J. C., Naha, P. C., Lau, K. C., Chhour, P., Hastings, R., Moon, B. F., Stein, J. M., Witschey, W. R. T., McDonald, E. S., Maidment, A. D. A., et al. (2018) · Nanoscale · doi:10.1039/c8nr03741h · Cited by 63 · see citing works
Kim, M., Ma, D. J., Calligaris, D., Zhang, S., Feathers, R. W., Vaubel, R. A., Meaux, I., Mladek, A. C., Parrish, K. E., Jin, F., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0600 · Cited by 39 · see citing works
- Authors
- McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Radiology
- Published
- 2015-06
- Volume
- 275
- Issue
- 3
- Pages
- 772-782
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2169262628
- Cited by
- 1,358
- References
- 27
- Citations by year
- 2026: 48 · 2025: 55 · 2024: 62 · 2023: 98 · 2022: 95 · 2021: 129 · 2020: 152 · 2019: 148 · 2018: 181 · 2017: 181 · 2016: 160 · 2015: 46 · 2014: 2
- FWCI
- 76.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Keywords
- gadolinium-based contrast agents, gadolinium deposition, neuronal tissue, T1-weighted signal intensity, postmortem brain, normal renal function, capillary endothelium, neurotoxicity
- MeSH terms
- Adult, Aged, Aged, 80 and over, Brain, Contrast Media, Gadolinium, Humans, Magnetic Resonance Imaging, Middle Aged, Retrospective Studies, Tissue Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review